Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Allegra A et al. – This case offers the occasion to emphasize the importance of medium–term and long–term hemovigilance also in other kind of patients than in subjects on immunosuppressive therapy. A deeper follow–up is advisable even in patients showing an unexplainable worsening of their hematological conditions.

Related Articles

Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura
International Journal of Hematology, 10/12/09    Relevance Score: 70%

Immune thrombocytopenia associated with Mycoplasma pneumoniae infection: a case report and review of literature
Blood Coagulation & Fibrinolysis, 10/07/09    Relevance Score: 68%

Refractory chronic immune thrombocytopenic purpura in a child with acute lymphoblastic leukemia
International Journal of Hematology, 10/13/09    Relevance Score: 67%

Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura
Blood, 10/02/09    Relevance Score: 67%

Romiplostim in chronic immune thrombocytopenic purpura
Clinical Therapeutics, 10/23/09    Relevance Score: 66%

Today in Coagulation/Bleeding Dz...keeping you current

Kasabach–Merritt phenomenon: a single centre experience
European Journal of Haematology, 12/10/09

Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies
Best Practice & Research: Clinical Haematology , 12/10/09

Developments in factor Xa inhibitors for the treatment of thromboembolic disorders
Medicinal Research Reviews, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address